» Articles » PMID: 34765549

Development and Validation of a Radiomics Model Based on F-FDG PET of Primary Gastric Cancer for Predicting Peritoneal Metastasis

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Nov 12
PMID 34765549
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The aim of this study was to develop a preoperative positron emission tomography (PET)-based radiomics model for predicting peritoneal metastasis (PM) of gastric cancer (GC).

Methods: In this study, a total of 355 patients (109PM+, 246PM-) who underwent preoperative fluorine-18-fludeoxyglucose (F-FDG) PET images were retrospectively analyzed. According to a 7:3 ratio, patients were randomly divided into a training set and a validation set. Radiomics features and metabolic parameters data were extracted from PET images. The radiomics features were selected by logistic regression after using maximum relevance and minimum redundancy (mRMR) and the least shrinkage and selection operator (LASSO) method. The radiomics models were based on the rest of these features. The performance of the models was determined by their discrimination, calibration, and clinical usefulness in the training and validation sets.

Results: After dimensionality reduction, 12 radiomics feature parameters were obtained to construct radiomics signatures. According to the results of the multivariate logistic regression analysis, only carbohydrate antigen 125 (CA125), maximum standardized uptake value (SUVmax), and the radiomics signature showed statistically significant differences between patients (P<0.05). A radiomics model was developed based on the logistic analyses with an AUC of 0.86 in the training cohort and 0.87 in the validation cohort. The clinical prediction model based on CA125 and SUVmax was 0.76 in the training set and 0.69 in the validation set. The comprehensive model, which contained a rad-score and the clinical factor (CA125) as well as the metabolic parameter (SUVmax), showed promising performance with an AUC of 0.90 in the training cohort and 0.88 in the validation cohort, respectively. The calibration curve showed the actual rate of the nomogram-predicted probability of peritoneal metastasis. Decision curve analysis (DCA) also demonstrated the good clinical utility of the radiomics nomogram.

Conclusions: The comprehensive model based on the rad-score and other factors (SUVmax, CA125) can provide a novel tool for predicting peritoneal metastasis of gastric cancer patients preoperatively.

Citing Articles

Development and validation of a machine learning-based F-fluorodeoxyglucose PET/CT radiomics signature for predicting gastric cancer survival.

Zhi H, Xiang Y, Chen C, Zhang W, Lin J, Gao Z Cancer Imaging. 2024; 24(1):99.

PMID: 39080806 PMC: 11290137. DOI: 10.1186/s40644-024-00741-4.


ASO Author Reflections: Preoperative Noninvasive Prediction of Peritoneal Metastasis in Advanced Gastric Cancer: A F-FDG PET/CT Radiomics-Based Multimodality Fusion Model.

Chen H, Chen Y, Dong Y, Li G, Li S, Yu J Ann Surg Oncol. 2024; 31(10):6972-6973.

PMID: 39020112 DOI: 10.1245/s10434-024-15777-w.


Deep learning radiomics model based on PET/CT predicts PD-L1 expression in non-small cell lung cancer.

Li B, Su J, Liu K, Hu C Eur J Radiol Open. 2024; 12:100549.

PMID: 38304572 PMC: 10831499. DOI: 10.1016/j.ejro.2024.100549.


Imaging Evaluation of Peritoneal Metastasis: Current and Promising Techniques.

Fu C, Zhang B, Guo T, Li J Korean J Radiol. 2024; 25(1):86-102.

PMID: 38184772 PMC: 10788608. DOI: 10.3348/kjr.2023.0840.


Nuclear medicine radiomics in digestive system tumors: Concept, applications, challenges, and future perspectives.

Huang W, Tao Z, Younis M, Cai W, Kang L View (Beijing). 2024; 4(6).

PMID: 38179181 PMC: 10766416. DOI: 10.1002/VIW.20230032.


References
1.
Fujitani K, Yang H, Mizusawa J, Kim Y, Terashima M, Han S . Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol. 2016; 17(3):309-318. DOI: 10.1016/S1470-2045(15)00553-7. View

2.
Halabi S, Lin C, Kelly W, Fizazi K, Moul J, Kaplan E . Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer. J Clin Oncol. 2014; 32(7):671-7. PMC: 3927736. DOI: 10.1200/JCO.2013.52.3696. View

3.
Hustinx R, Benard F, Alavi A . Whole-body FDG-PET imaging in the management of patients with cancer. Semin Nucl Med. 2002; 32(1):35-46. DOI: 10.1053/snuc.2002.29272. View

4.
Wei J, Wu N, Liu B . Regional but fatal: Intraperitoneal metastasis in gastric cancer. World J Gastroenterol. 2016; 22(33):7478-85. PMC: 5011663. DOI: 10.3748/wjg.v22.i33.7478. View

5.
Bogowicz M, Vuong D, Huellner M, Pavic M, Andratschke N, Gabrys H . CT radiomics and PET radiomics: ready for clinical implementation?. Q J Nucl Med Mol Imaging. 2019; 63(4):355-370. DOI: 10.23736/S1824-4785.19.03192-3. View